Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumors.
How Trump’s approach to regulating AI in health care could diverge from Biden’s
A lot has happened with artificial intelligence since President-elect Donald Trump was last in the White House. Nudged into action by the advent of generative